{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:06:17Z","timestamp":1777395977914,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["EP\/Y014596\/1"],"award-info":[{"award-number":["EP\/Y014596\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejpb.2025.114933","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T01:32:33Z","timestamp":1763083953000},"page":"114933","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A strategy to prevent ciprofloxacin induced corneal toxicity"],"prefix":"10.1016","volume":"218","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8300-3148","authenticated-orcid":false,"given":"Parag","family":"Roy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7369-4611","authenticated-orcid":false,"given":"Ois\u00edn N.","family":"Kavanagh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ejpb.2025.114933_b0005","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/S0886-3350(01)00893-8","article-title":"Ciprofloxacin microprecipitates and macroprecipitates in the human corneal epithelium","volume":"27","author":"Eiferman","year":"2001","journal-title":"J. Cataract. Refract. Surg."},{"issue":"4","key":"10.1016\/j.ejpb.2025.114933_b0010","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jcjo.2014.04.013","article-title":"Corneal deposit after topical ciprofloxacin as postoperative medication after cataract surgery","volume":"49","author":"Vijay Zawar","year":"2014","journal-title":"Can. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.ejpb.2025.114933_b0015","doi-asserted-by":"crossref","DOI":"10.1001\/jamaophthalmol.2019.0921","article-title":"Ciprofloxacin corneal deposits with complete dissipation after switching to moxifloxacin","volume":"138","author":"Quan","year":"2020","journal-title":"JAMA Ophthalmol."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114933_b0020","article-title":"Corneal deposit of ciprofloxacin after laser assisted subepithelial keratomileusis procedure: A case report","volume":"2010","author":"De Benedetti","year":"2010","journal-title":"J. Ophthalmol."},{"issue":"6","key":"10.1016\/j.ejpb.2025.114933_b0025","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/S0002-9394(03)00636-6","article-title":"Corneal ciprofloxacin precipitation during bacterial keratitis","volume":"136","author":"Wilhelmus","year":"2003","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2025.114933_b0030","unstructured":"Ciloxan 0.3% w\/v eye drops solution - Summary of Product Characteristics (SmPC) - (emc) | 836. https:\/\/www.medicines.org.uk\/emc\/product\/836\/smpc#gref (accessed 2025-05-29)."},{"issue":"6","key":"10.1016\/j.ejpb.2025.114933_b0035","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1136\/bjo.79.6.606","article-title":"Topical 0.3% ciprofloxacin, norfloxacin, and ofloxacin in treatment of bacterial keratitis: A new method for comparative evaluation of ocular drug penetration","volume":"79","author":"Diamond","year":"1995","journal-title":"Br. J. Ophthalmol."},{"issue":"25","key":"10.1016\/j.ejpb.2025.114933_b0040","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1056\/NEJMra1601611","article-title":"Crystallopathies","volume":"374","author":"Mulay","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"44","key":"10.1016\/j.ejpb.2025.114933_b0045","doi-asserted-by":"crossref","first-page":"32063","DOI":"10.1039\/D4RA04469J","article-title":"O. Cystine crystal nucleation and decay in the context of cystinuria pathogenesis and treatment","volume":"14","author":"Noble","year":"2024","journal-title":"RSC Adv."},{"issue":"15","key":"10.1016\/j.ejpb.2025.114933_b0050","doi-asserted-by":"crossref","first-page":"5525","DOI":"10.1021\/ja401309d","article-title":"Determination of specific binding interactions at L-cystine crystal surfaces with chemical force microscopy","volume":"135","author":"Mandal","year":"2013","journal-title":"J. Am. Chem. Soc."},{"issue":"6002","key":"10.1016\/j.ejpb.2025.114933_b0055","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1126\/science.1191968","article-title":"Crystal growth inhibitors for the prevention of L-cystine kidney stones through molecular design","volume":"330","author":"Rimer","year":"2010","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.ejpb.2025.114933_b0060","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1021\/jacs.4c14629","article-title":"Vitamin B2 operates by dual thermodynamic and kinetic mechanisms to selectively tailor urate crystallization","volume":"147","author":"Li","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"3","key":"10.1016\/j.ejpb.2025.114933_b0065","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.drudis.2018.11.023","article-title":"Pharmaceutical cocrystals: From serendipity to design to application","volume":"24","author":"Kavanagh","year":"2019","journal-title":"Drug Discov. Today"},{"issue":"8","key":"10.1016\/j.ejpb.2025.114933_b0070","doi-asserted-by":"crossref","first-page":"6059","DOI":"10.1021\/acs.cgd.3c00590","article-title":"Tuning the pharmacokinetic performance of quercetin by cocrystallization","volume":"23","author":"Haskins","year":"2023","journal-title":"Cryst. Growth Des."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114933_b0075","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0378-5173(97)00427-4","article-title":"Solubility characteristics of three fluoroquinolone ophthalmic solutions in an in vitro tear model","volume":"164","author":"Firestone","year":"1998","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114933_b0080","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/jop.1986.2.67","article-title":"Topical ocular drug delivery: Recent developments and future challenges","volume":"2","author":"Lee","year":"1986","journal-title":"J. Ocul. Pharmacol."},{"key":"10.1016\/j.ejpb.2025.114933_b0085","series-title":"An Introduction to Clinical Pharmaceutics","author":"Kavanagh","year":"2025"},{"issue":"3","key":"10.1016\/j.ejpb.2025.114933_b0090","first-page":"264","article-title":"Determination of tear volume and tear flow","volume":"5","author":"Mishima","year":"1966","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"6","key":"10.1016\/j.ejpb.2025.114933_b0095","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/eye.2001.250","article-title":"Scanning electron microscopic study of a ciloxan bottle blocked by ciprofloxacin crystals","volume":"15","author":"John","year":"2001","journal-title":"Eye"},{"issue":"1","key":"10.1016\/j.ejpb.2025.114933_b0100","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0022-0248(96)00056-5","article-title":"HABIT95 \u2014 a program for predicting the morphology of molecular crystals as a function of the growth environment","volume":"166","author":"Clydesdale","year":"1996","journal-title":"J. Cryst. Growth"},{"issue":"1","key":"10.1016\/j.ejpb.2025.114933_b0105","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1021\/ja208647n","article-title":"Packing interactions in hydrated and anhydrous forms of the antibiotic ciprofloxacin: A solid-state NMR, X-ray diffraction, and computer simulation study","volume":"134","author":"Mafra","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejpb.2025.114933_b0110","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1136\/bmjophth-2021-000892","article-title":"Impact of benzalkonium chloride-preserved and preservative-free latanoprost eye drops on cultured human conjunctival goblet cells upon acute exposure and differences in physicochemical properties of the eye drops","volume":"6","author":"M\u00fcllertz","year":"2021","journal-title":"BMJ Open Ophth"},{"key":"10.1016\/j.ejpb.2025.114933_b0115","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1021\/cg800565a","article-title":"Hierarchy of Supramolecular Synthons: persistent carboxylic acid\u22efpyridine hydrogen bonds in cocrystals that also contain a hydroxyl moiety","volume":"8","author":"Shattock","year":"2008","journal-title":"In Crystal Growth and Design"},{"issue":"3","key":"10.1016\/j.ejpb.2025.114933_b0120","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1021\/cg301299e","article-title":"A Supramolecular assembly formed by heteroassociation of ciprofloxacin and norfloxacin in the solid state: Co-crystal synthesis and characterization","volume":"13","author":"Vitorino","year":"2013","journal-title":"Cryst. Growth Des."},{"issue":"2","key":"10.1016\/j.ejpb.2025.114933_b0125","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3390\/pharmaceutics12020187","article-title":"Formulating a stable mannitol infusion while maintaining hyperosmolarity","volume":"12","author":"Kavanagh","year":"2020","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.ejpb.2025.114933_b0130","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1021\/acs.nanolett.4c05867","article-title":"Mechanism of water freezing in solutions: Solutes affect the formation of critical ice nuclei","volume":"25","author":"Li","year":"2025","journal-title":"Nano Lett."},{"issue":"10","key":"10.1016\/j.ejpb.2025.114933_b0135","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3390\/cryst7100302","article-title":"Modulating nucleation by kosmotropes and chaotropes: Testing the waters","volume":"7","author":"Rao","year":"2017","journal-title":"Crystals"},{"issue":"4","key":"10.1016\/j.ejpb.2025.114933_b0140","doi-asserted-by":"crossref","first-page":"400","DOI":"10.2174\/138920109788488941","article-title":"Effect of additives on protein aggregation","volume":"10","author":"Hamada","year":"2009","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"28","key":"10.1016\/j.ejpb.2025.114933_b0145","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.1039\/C9CE00404A","article-title":"Template-induced nucleation for controlling crystal polymorphism: From molecular mechanisms to applications in pharmaceutical processing","volume":"21","author":"Parambil","year":"2019","journal-title":"CrstEngComm"},{"key":"10.1016\/j.ejpb.2025.114933_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2024.03.034","article-title":"An analysis of multidrug multicomponent crystals as tools for drug development","volume":"369","author":"Kavanagh","year":"2024","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.ejpb.2025.114933_b0155","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1021\/cg801039j","article-title":"Solubility advantage of pharmaceutical cocrystals","volume":"9","author":"Good","year":"2009","journal-title":"Cryst. Growth Des."},{"issue":"3","key":"10.1016\/j.ejpb.2025.114933_b0160","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/112067219600600312","article-title":"Comparative evaluation of efficacy and safety of ciprofloxacin and norfloxacin ophthalmic solutions","volume":"6","author":"Adenis","year":"1996","journal-title":"Eur. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114933_b0165","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0378-5173(95)04332-2","article-title":"The effect of pH, buffer type and drug concentration on the photodegradation of ciprofloxacin","volume":"132","author":"Torniainen","year":"1996","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ejpb.2025.114933_b0170","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/archopht.1981.03930010303017","article-title":"Normal human tear pH by direct measurement","volume":"99","author":"Abelson","year":"1981","journal-title":"Arch. Ophthalmol."},{"issue":"4","key":"10.1016\/j.ejpb.2025.114933_b0175","first-page":"747","article-title":"Buffering in human tears: pH responses to acid and base challenge","volume":"30","author":"Carney","year":"1989","journal-title":"Invest. Ophthalmol. Vis. Sci."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964112500311X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964112500311X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T17:42:58Z","timestamp":1766079778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S093964112500311X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":35,"alternative-id":["S093964112500311X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114933","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A strategy to prevent ciprofloxacin induced corneal toxicity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114933","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114933"}}